首页> 外文期刊>Experimental parasitology >Efficacy of chimeric DNA vaccines encoding Eimeria tenella 5401 and chicken IFN-gamma or IL-2 against coccidiosis in chickens
【24h】

Efficacy of chimeric DNA vaccines encoding Eimeria tenella 5401 and chicken IFN-gamma or IL-2 against coccidiosis in chickens

机译:编码艾美尔球虫5401和鸡IFN-γ或IL-2的嵌合DNA疫苗对鸡球虫病的功效

获取原文
获取原文并翻译 | 示例
           

摘要

Chimeric DNA vaccines encoding Eimeria tenella (E. tenella) surface antigen 5401 were constructed and their efficacies against E. tenella challenge were studied. The open reading frame (ORF) of 5401 was cloned into the prokaryotic expression vector pGEX-4T2 to express the recombinant protein and the expressed recombinant protein was identified by Western blot. The ORF of 5401 and chicken cytokine gene IFN-gamma or IL-2 were cloned into the eukaryotic expression vector pVAX1 consecutively to construct DNA vaccines pVAX-5401-IFN-gamma, pVAX-5401-IL-2 and pVAX-5401. The expression of aim genes in vivo was detected by reverse transcription-polymerase chain reaction and Western blot. Fourteen-day-old chickens were inoculated twice at an interval of 7 days with 100 mu g of plasmids pVAX-5401, pVAX-5401-IFN-gamma and pVAX-5401-IL-2 or 200 fig of recombinant 5401 protein by leg intramuscular injection, respectively. Seven days after the second inoculation, all chickens except the unchallenged control group were challenged orally with 5 x 10(4) sporulated oocysts of E. tenella. Seven days after challenge, all chickens were weighted and slaughtered to determine the effects of immunization. The results showed the recombinant protein was about 90 kDa and reacted with antiserum against soluble sporozoites. The animal experiment showed that all the DNA vaccines pVAX-5401, pVAX-5401-IFN-gamma or pVAX-5401-1-2 and the recombinant 5401 protein could obviously alleviate body weight loss and cecal lesions as compared with non-vaccinated challenged control and empty vector pVAX1control. Furthermore, pVAX-5401-IFN-gamma or pVAX-5401-1-2 induced anti-coccidial index (ACI) of 180.01 or 177.24 which were significantly higher than that of pVAX-5401. The results suggested that 5401 was an effective candidate antigen for vaccine. This finding also suggested that chicken IFN-gamma or IL-2 could effectively improve the efficacies of DNA vaccines against avian coccidiosis. (C) 2015 Elsevier Inc. All rights reserved.
机译:构建了编码艾美球虫(Eimeria tenella)(E。tenella)表面抗原5401的嵌合DNA疫苗,并研究了它们对抗艾美球虫攻击的功效。将5401的开放阅读框(ORF)克隆到原核表达载体pGEX-4T2中以表达重组蛋白,并通过蛋白质印迹法鉴定表达的重组蛋白。将5401的ORF和鸡细胞因子基因IFN-γ或IL-2连续克隆到真核表达载体pVAX1中,以构建DNA疫苗pVAX-5401-IFN-γ,pVAX-5401-IL-2和pVAX-5401。通过逆转录-聚合酶链反应和蛋白质印迹检测了目的基因在体内的表达。十四天大的鸡在7天的间隔内分别两次接种100μg质粒pVAX-5401,pVAX-5401-IFN-γ和pVAX-5401-IL-2或200图无花果重组5401蛋白,通过腿肌肉注射注射。第二次接种后7天,除无挑战性对照组外,所有鸡均口服5 x 10(4)孢子形成的大肠杆菌的卵囊攻击。攻击后7天,对所有鸡称重并宰杀以确定免疫效果。结果表明重组蛋白约为90 kDa,并与抗可溶性子孢子的抗血清反应。动物实验表明,与未接种疫苗的对照组相比,所有的DNA疫苗pVAX-5401,pVAX-5401-IFN-γ或pVAX-5401-1-2和重组5401蛋白均能明显减轻体重减轻和盲肠病变。和空向量pVAX1control。此外,pVAX-5401-IFN-γ或pVAX-5401-1-2诱导的抗球虫指数(ACI)为180.01或177.24,显着高于pVAX-5401。结果表明5401是疫苗的有效候选抗原。该发现还表明,鸡IFN-γ或IL-2可以有效地提高针对禽球虫病的DNA疫苗的效力。 (C)2015 Elsevier Inc.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号